Rights and permissions
About this article
Cite this article
33B3.1: has similar efficacy and fewer adverse effects than antithymocyte globulin as prophylaxis of renal graft rejection. Inpharma Wkly. 735, 6 (1990). https://doi.org/10.2165/00128413-199007350-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007350-00011